
Biogen Inc.
BIIBNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$195.55
Day High
$198.46
Day Low
$195.11
Prev. Close
$196.39
VolumeShares traded today.
1.53M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$28.94B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
21.03
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$205.97
52W LowLowest price over the past 52 weeks.
$121.05
50D MAAverage closing price over the last 50 trading days.
$186.72
200D MAAverage closing price over the last 200 trading days.
$170.55
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+3.4%1M
+0.8%6M
+7.7%YTD
+10.2%1Y
+49.5%About
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. The company's primary products are dimethyl fumarate (Tecfidera), diroximel fumarate (Vumerity), interferon beta-1a (AVONEX), peginterferon beta-1a (Plegridy), and natalizumab (Tysabri), all for the treatment of multiple sclerosis ; nusinersen (Spinraza) for the treatment of spinal muscular atrophy ; omaveloxolone (Skyclarys) for the treatment of Friedreich's ataxia ; tofersen (Qalsody) for the treatment of ALS; and dimethyl fumarate (Fumaderm) for the treatment of severe plaque psoriasis. The company also produces 5 biosimilars and has collaborations with Genentech for several drugs.
www.biogen.com/Company Facts
Similar stocks
HealthcareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade BIIB
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.